Sign in / Join Now
ETFs & Funds
Cancer Genetics (CGIX): FQ3 EPS of -$0.61 beats by $0.10.Revenue of $1.7M beats by $0.1M
Add a reply...
Latest StockTalks »
people get CGIX breaking news and analysis by email alert.
Get email alerts on CGIX »
Cancer Genetics, Inc.
Get latest price
From other sites
Cancer Genetics, Inc. To Present At Two Upcoming Investor Conferences During September
at TheStreet (Wed, 7:30AM)
Cancer Genetics, Inc. Announces A Global Partnership With BARC Global Central Laboratory To Offer Comprehensive Clinical Trial And Companion Diagnostic Solutions For The Oncology Industry
at TheStreet (Tue, 7:30AM)
Cancer Genetics Announces $5.5 Million Registered Direct Offering
at TheStreet (Sep 9, 2016)
Cancer Genetics, Inc. To Present At The Rodman & Renshaw 18th Annual Global Investment Conference
at TheStreet (Sep 8, 2016)
Cancer Genetics, Inc. Strengthens Position As A Leader In Myeloid Cancer Diagnosis And Management Receiving New York State Approval For Focus::Myeloid™, A Targeted NGS Panel For Improved Diagnosis, Risk Stratification, And Therapy Selection Of Patients With Myeloid Cancers
at TheStreet (Aug 17, 2016)